HIGHLIGHTS
- who: Nuria Maicas and colleagues from the Department of Nephrology, Radboud University Medical Center, Nijmegen, the Netherlands, Department have published the research: Human Alpha-1-Antitrypsin (hAAT) therapy reduces renal dysfunction and acute tubular necrosis in a murine model of bilateral kidney ischemia-reperfusion injury, in the Journal: PLOS ONE | DOI:10.1371/journal.pone [0168981]. February 24, 2017 of /1371/
- what: The aim of this study was to investigate the effects of human AAT (hAAT) monotherapy during the early and recovery phase of ischemia-induced acute kidney injury. The focus of current research is . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.